Organization News Archives - Glioblastoma Foundation https://staging.glioblastomafoundation.org/news/category/organization-news Transforming Glioblastoma Therapy Fri, 12 Apr 2024 21:30:59 +0000 en-US hourly 1 /wp-content/uploads/2022/11/index.png Organization News Archives - Glioblastoma Foundation https://staging.glioblastomafoundation.org/news/category/organization-news 32 32 What is the Prognosis of Glioblastoma? https://staging.glioblastomafoundation.org/news/what-is-the-prognosis-of-glioblastoma Fri, 12 Apr 2024 16:46:41 +0000 https://staging.glioblastomafoundation.org/?p=2680 Glioblastoma, or Glioblastoma  Multiforme (GBM), is an aggressive stage 4 brain cancer.  Nearly half of all malignant brain tumors are glioblastomas. The prognosis for glioblastoma is generally very poor and current treatments often fall short. Glioblastoma is the most common malignant primary brain tumor, and many refer to it as the “emperor of all cancers.” […]

The post What is the Prognosis of Glioblastoma? appeared first on Glioblastoma Foundation.

]]> Pseudo-progression: A Key Focus Area of the Glioblastoma Foundation https://staging.glioblastomafoundation.org/news/pseudoprogression-a-key-focus-area-of-the-glioblastoma-foundation Mon, 18 Sep 2023 18:20:39 +0000 https://staging.glioblastomafoundation.org/?p=2435 Pseudoprogression vs. Progressive Disease Pseudoprogression is the phenomenon of an appearance of tumor growth on brain scans post chemotherapy and radiation when there is no tumor growth. Pseudoprogression imitates tumor enlargement and is usually confused with an actual progression of the disease for many patients with glioblastoma who are visiting their doctors for follow-up exams. […]

The post Pseudo-progression: A Key Focus Area of the Glioblastoma Foundation appeared first on Glioblastoma Foundation.

]]> Extraordinary Lives: Caroline Wright https://staging.glioblastomafoundation.org/news/extraordinary-lives-caroline-wright Wed, 19 Jul 2023 23:56:12 +0000 https://staging.glioblastomafoundation.org/?p=2420 Caroline Wright was diagnosed with Glioblastoma at the young age of 32.  After her diagnosis, Caroline found hope in the support of her community, her own strength, and surprisingly soup! Caroline is a 7-year Glioblastoma survivor. Learn how she is now giving back to the community that gave her strength through soup! The Glioblastoma Foundation […]

The post Extraordinary Lives: Caroline Wright appeared first on Glioblastoma Foundation.

]]> Glioblastoma Foundation Funds Nanoparticle Drug Delivery Study https://staging.glioblastomafoundation.org/news/glioblastoma-foundation-funds-nanoparticle-drug-delivery-study Mon, 17 Apr 2023 15:04:43 +0000 https://staging.glioblastomafoundation.org/?p=2402 The Glioblastoma Foundation is pleased to announce the funding of a new nanoparticle delivery study for glioblastoma at Yale University. Dr. Mark Saltzman, Professor of Biomedical Engineering, and Physiology, at the Yale Cancer Center is leading a study to develop  nanoparticles to target microRNAs, which regulate cancer gene expression. Drug delivery to the site of […]

The post Glioblastoma Foundation Funds Nanoparticle Drug Delivery Study appeared first on Glioblastoma Foundation.

]]> Glioblastoma Foundation Funds Caregiver Study https://staging.glioblastomafoundation.org/news/glioblastoma-foundation-funds-caregiver-study Thu, 15 Dec 2022 21:29:27 +0000 https://staging.glioblastomafoundation.org/?p=2313 A Glioblastoma  diagnosis can exert undue stress on families and primary caregivers. Glioblastoma Foundation is pleased to announce that we are funding a new study led by the Glioblastoma Foundation’s very own Drs. Laura Porter and Katherine Ramos. This ground-breaking family and caregiver study will focus on providing psychoeducation and support for Glioblastoma caregivers and […]

The post Glioblastoma Foundation Funds Caregiver Study appeared first on Glioblastoma Foundation.

]]> Glioblastoma Foundation funds study on long-term glioblastoma survival https://staging.glioblastomafoundation.org/news/glioblastoma-foundation-funds-study-on-long-term-vs-short-term-glioblastoma-survival Wed, 20 Jul 2022 12:59:54 +0000 https://staging.glioblastomafoundation.org/?p=2140 The Glioblastoma Foundation is pleased to announce the funding of a new population-based survival study for glioblastoma at MGH at Harvard Medical Center. Dr. Eugene Semenov will lead the study to examine population-based differences in long-term vs short-term glioblastoma survival. As survival statistics for glioblastoma start to slowly improve, the Glioblastoma Foundation is focused on […]

The post Glioblastoma Foundation funds study on long-term glioblastoma survival appeared first on Glioblastoma Foundation.

]]> Extraordinary Lives: Jeffrey Lindgren https://staging.glioblastomafoundation.org/news/extraordinary-lives-jeffrey-lindgren Tue, 03 May 2022 18:44:04 +0000 https://staging.glioblastomafoundation.org/?p=2115 Jeff Lindgren was diagnosed with Glioblastoma in April 2021. Since his diagnosis, Jeff and his wife Margaret have been committed to beating glioblastoma and raising funding for new treatments supported by the Glioblastoma Foundation. The Glioblastoma Foundation is proud to share this patient spotlight and a look into one of the extraordinary lives impacted by […]

The post Extraordinary Lives: Jeffrey Lindgren appeared first on Glioblastoma Foundation.

]]> Glioblastoma Foundation funds study on targeted drug therapy for Glioblastoma https://staging.glioblastomafoundation.org/news/glioblastoma-foundation-funds-study-on-targeted-drug-therapy-for-glioblastoma Wed, 20 Apr 2022 14:24:50 +0000 https://staging.glioblastomafoundation.org/?p=2144 Glioblastoma has proven to be one of the most difficult cancers to treat and cure. Today, on Glioblastoma Awareness Day, the Glioblastoma Foundation is pleased to announce that we are funding a new study led by Dr. Vinay Puduvalli, Chair of the Department of Neuro-Oncology at MD Anderson Cancer Center, to examine glioblastoma cancer metabolism […]

The post Glioblastoma Foundation funds study on targeted drug therapy for Glioblastoma appeared first on Glioblastoma Foundation.

]]> Malignant Brain Tumor Diagnosis: What it Means & What to Expect https://staging.glioblastomafoundation.org/news/malignant-brain-tumor Thu, 13 Jan 2022 18:11:27 +0000 https://staging.glioblastomafoundation.org/?p=2013 If you or a loved one have recently received a brain tumor diagnosis, you’re probably searching for answers. An initial diagnosis of a brain tumor is generally made after a neurological assessment and imaging tests. These tests may include magnetic resonance imaging (MRI) or computerized tomography (CT). If an abnormality is detected, a neurosurgeon will […]

The post Malignant Brain Tumor Diagnosis: What it Means & What to Expect appeared first on Glioblastoma Foundation.

]]> Glioblastoma Foundation Partners with Continuity Pharma to Bring Glioblastoma Drug to Patients https://staging.glioblastomafoundation.org/news/glioblastoma-foundation-and-continuity-pharma-partner-to-bring-glioblastoma-drug-to-patients Wed, 22 Dec 2021 18:27:44 +0000 https://staging.glioblastomafoundation.org/?p=1984 The Glioblastoma Foundation is proud to announce a partnership with Continuity Pharma to bring the glioblastoma drug Lomustine to patients more affordably and accessibly.  There are currently very few effective therapies for recurrent glioblastoma.  Lomustine is one of the only effective therapies currently FDA approved for recurrent glioblastoma and is used as the standard of […]

The post Glioblastoma Foundation Partners with Continuity Pharma to Bring Glioblastoma Drug to Patients appeared first on Glioblastoma Foundation.

]]>